Proton pump inhibitor-related headaches: A nationwide population-based case-crossover study in Taiwan

Jen Feng Liang, Yung Tai Chen, Jong Ling Fuh, Szu Yuan Li, Tzeng Ji Chen, Chao Hsiun Tang, Shuu Jiun Wang

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Headaches resulting from proton pump inhibitor (PPI) use could cause discontinuation of PPI in as many as 40% of patients who experience such headaches. Previous studies focusing on acute headache risk from PPI use are rare and limited to clinical trials of a single PPI. Objectives: To investigate the association between PPI use and headache with a nationwide population-based case-crossover study. Methods: Records containing the first diagnosis of any headache, including migraine and tension-type headaches, were retrieved from Taiwan National Health Insurance Database (19982010).We compared the rates of PPI use for cases and controls during time windows of 7, 14, and 28 days. The adjusted self-matched odds ratios (ORs) and 95% confidence intervals (CIs) from a conditional logistic regression model were used to determine the association between PPI use and headache. Results: Overall, 314,210 patients with an initial diagnosis of any headache during the study period were enrolled. The adjusted ORs for headache risk after PPI exposure were calculated for three time periods (within 7 days1.41, p0.002, 95% CI 1.141.74; within 14 days1.36, p

Original languageEnglish
Pages (from-to)203-210
Number of pages8
JournalCephalalgia
Volume35
Issue number3
DOIs
Publication statusPublished - Mar 26 2015

Fingerprint

Proton Pump Inhibitors
Taiwan
Cross-Over Studies
Headache
Population
Logistic Models
Odds Ratio
Confidence Intervals
Tension-Type Headache
National Health Programs
Migraine Disorders
Clinical Trials
Databases

Keywords

  • Headache
  • incidence
  • proton pump inhibitor
  • risk
  • Taiwan

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Proton pump inhibitor-related headaches : A nationwide population-based case-crossover study in Taiwan. / Liang, Jen Feng; Chen, Yung Tai; Fuh, Jong Ling; Li, Szu Yuan; Chen, Tzeng Ji; Tang, Chao Hsiun; Wang, Shuu Jiun.

In: Cephalalgia, Vol. 35, No. 3, 26.03.2015, p. 203-210.

Research output: Contribution to journalArticle

Liang, Jen Feng ; Chen, Yung Tai ; Fuh, Jong Ling ; Li, Szu Yuan ; Chen, Tzeng Ji ; Tang, Chao Hsiun ; Wang, Shuu Jiun. / Proton pump inhibitor-related headaches : A nationwide population-based case-crossover study in Taiwan. In: Cephalalgia. 2015 ; Vol. 35, No. 3. pp. 203-210.
@article{d3744a120a1242efa6df25b2aa6c4b35,
title = "Proton pump inhibitor-related headaches: A nationwide population-based case-crossover study in Taiwan",
abstract = "Background: Headaches resulting from proton pump inhibitor (PPI) use could cause discontinuation of PPI in as many as 40{\%} of patients who experience such headaches. Previous studies focusing on acute headache risk from PPI use are rare and limited to clinical trials of a single PPI. Objectives: To investigate the association between PPI use and headache with a nationwide population-based case-crossover study. Methods: Records containing the first diagnosis of any headache, including migraine and tension-type headaches, were retrieved from Taiwan National Health Insurance Database (19982010).We compared the rates of PPI use for cases and controls during time windows of 7, 14, and 28 days. The adjusted self-matched odds ratios (ORs) and 95{\%} confidence intervals (CIs) from a conditional logistic regression model were used to determine the association between PPI use and headache. Results: Overall, 314,210 patients with an initial diagnosis of any headache during the study period were enrolled. The adjusted ORs for headache risk after PPI exposure were calculated for three time periods (within 7 days1.41, p0.002, 95{\%} CI 1.141.74; within 14 days1.36, p",
keywords = "Headache, incidence, proton pump inhibitor, risk, Taiwan",
author = "Liang, {Jen Feng} and Chen, {Yung Tai} and Fuh, {Jong Ling} and Li, {Szu Yuan} and Chen, {Tzeng Ji} and Tang, {Chao Hsiun} and Wang, {Shuu Jiun}",
year = "2015",
month = "3",
day = "26",
doi = "10.1177/0333102414535114",
language = "English",
volume = "35",
pages = "203--210",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Proton pump inhibitor-related headaches

T2 - A nationwide population-based case-crossover study in Taiwan

AU - Liang, Jen Feng

AU - Chen, Yung Tai

AU - Fuh, Jong Ling

AU - Li, Szu Yuan

AU - Chen, Tzeng Ji

AU - Tang, Chao Hsiun

AU - Wang, Shuu Jiun

PY - 2015/3/26

Y1 - 2015/3/26

N2 - Background: Headaches resulting from proton pump inhibitor (PPI) use could cause discontinuation of PPI in as many as 40% of patients who experience such headaches. Previous studies focusing on acute headache risk from PPI use are rare and limited to clinical trials of a single PPI. Objectives: To investigate the association between PPI use and headache with a nationwide population-based case-crossover study. Methods: Records containing the first diagnosis of any headache, including migraine and tension-type headaches, were retrieved from Taiwan National Health Insurance Database (19982010).We compared the rates of PPI use for cases and controls during time windows of 7, 14, and 28 days. The adjusted self-matched odds ratios (ORs) and 95% confidence intervals (CIs) from a conditional logistic regression model were used to determine the association between PPI use and headache. Results: Overall, 314,210 patients with an initial diagnosis of any headache during the study period were enrolled. The adjusted ORs for headache risk after PPI exposure were calculated for three time periods (within 7 days1.41, p0.002, 95% CI 1.141.74; within 14 days1.36, p

AB - Background: Headaches resulting from proton pump inhibitor (PPI) use could cause discontinuation of PPI in as many as 40% of patients who experience such headaches. Previous studies focusing on acute headache risk from PPI use are rare and limited to clinical trials of a single PPI. Objectives: To investigate the association between PPI use and headache with a nationwide population-based case-crossover study. Methods: Records containing the first diagnosis of any headache, including migraine and tension-type headaches, were retrieved from Taiwan National Health Insurance Database (19982010).We compared the rates of PPI use for cases and controls during time windows of 7, 14, and 28 days. The adjusted self-matched odds ratios (ORs) and 95% confidence intervals (CIs) from a conditional logistic regression model were used to determine the association between PPI use and headache. Results: Overall, 314,210 patients with an initial diagnosis of any headache during the study period were enrolled. The adjusted ORs for headache risk after PPI exposure were calculated for three time periods (within 7 days1.41, p0.002, 95% CI 1.141.74; within 14 days1.36, p

KW - Headache

KW - incidence

KW - proton pump inhibitor

KW - risk

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=84923932466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923932466&partnerID=8YFLogxK

U2 - 10.1177/0333102414535114

DO - 10.1177/0333102414535114

M3 - Article

C2 - 24853165

AN - SCOPUS:84923932466

VL - 35

SP - 203

EP - 210

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 3

ER -